FDA clears Merck type 2 diabetes medication - Pharmaceutical Technology

Links shared publicly online about this topic.

  • 0
    total visits

FDA clears Merck type 2 diabetes medication - Pharmaceutical Technology

pharmaceutical-technology.com —

The US Food and Drug Administration (FDA) has approved Merck's Juvisync, a once-daily therapy for type 2 diabetes that combines glucose-lowering medication sitagliptin, the active component of Januvia, with cholesterol-lowering medication...

View full resource at pharmaceutical-technology.com

Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Type 2 Diabetes, Drug, FDA, Merck & Co.

  • Share

Most Recently Shared on October 13, 2011 at 8:49 pm By:

Diabetes_Type2 Diabetes, Type 2

FDA clears Merck type 2 diabetes medication: The US Food and Drug Administration (FDA) has approved Merck's Juvi... http://t.co/ELs3eqV0

8 months ago...

Reply

Retweet

Favorite

Also Shared By:

Cholesterol OW Cholesterol OW

Advertisement